Paclitaxel and B7-H6 knockdown inhibit HepG2 hepatocellular carcinoma cell viability and migration, while enhancing apoptosis and cell cycle arrest.

Alipour S, Safdari Z, Khosravi N, Baghbani E, Karamali N, Mehdizadehfar E, Baradaran B

Open source

DOI
10.1007/s11033-026-12286-9
Published
2026 Jul 8
Container
Molecular biology reports
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s11033-026-12286-9,
  title = {Paclitaxel and B7-H6 knockdown inhibit HepG2 hepatocellular carcinoma cell viability and migration, while enhancing apoptosis and cell cycle arrest.},
  author = {Alipour S and Safdari Z and Khosravi N and Baghbani E and Karamali N and Mehdizadehfar E and Baradaran B},
  year = {2026},
  journal = {Molecular biology reports},
  doi = {10.1007/s11033-026-12286-9},
  url = {https://doi.org/10.1007/s11033-026-12286-9}
}

RIS

TY  - JOUR
TI  - Paclitaxel and B7-H6 knockdown inhibit HepG2 hepatocellular carcinoma cell viability and migration, while enhancing apoptosis and cell cycle arrest.
AU  - Alipour S
AU  - Safdari Z
AU  - Khosravi N
AU  - Baghbani E
AU  - Karamali N
AU  - Mehdizadehfar E
AU  - Baradaran B
PY  - 2026
JO  - Molecular biology reports
DO  - 10.1007/s11033-026-12286-9
UR  - https://doi.org/10.1007/s11033-026-12286-9
ER  - 

APA

S, A., Z, S., N, K., E, B., N, K., E, M., & B, B. (2026). Paclitaxel and B7-H6 knockdown inhibit HepG2 hepatocellular carcinoma cell viability and migration, while enhancing apoptosis and cell cycle arrest.. Molecular biology reports. https://doi.org/10.1007/s11033-026-12286-9

Source records